Page last updated: 2024-11-02

moxonidine and Cardiomyopathy, Dilated

moxonidine has been researched along with Cardiomyopathy, Dilated in 1 studies

moxonidine: structure given in first source

Cardiomyopathy, Dilated: A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.

Research Excerpts

ExcerptRelevanceReference
"Moxonidine was well tolerated in this single-dose study and resulted in a modest, dose-dependent, vasodilator response, with substantial reductions in systemic and pulmonary arterial blood pressure."6.69Acute hemodynamic and neurohumoral effects of moxonidine in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Aarsland, T; Dickstein, K; Køpp, U; Manhenke, C; McNay, J; Wiltse, C, 1999)
"Moxonidine was well tolerated in this single-dose study and resulted in a modest, dose-dependent, vasodilator response, with substantial reductions in systemic and pulmonary arterial blood pressure."2.69Acute hemodynamic and neurohumoral effects of moxonidine in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Aarsland, T; Dickstein, K; Køpp, U; Manhenke, C; McNay, J; Wiltse, C, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dickstein, K1
Manhenke, C1
Aarsland, T1
Køpp, U1
McNay, J1
Wiltse, C1

Trials

1 trial available for moxonidine and Cardiomyopathy, Dilated

ArticleYear
Acute hemodynamic and neurohumoral effects of moxonidine in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    The American journal of cardiology, 1999, Jun-15, Volume: 83, Issue:12

    Topics: Administration, Oral; Aged; Analysis of Variance; Antihypertensive Agents; Cardiomyopathy, Dilated;

1999